Shanghai Rongtai Health Technology Corp Ltd
SSE:603579
Intrinsic Value
Shanghai Rongtai Health Technology Corp., Ltd. engages in the design, research, development, production, and sale of massage apparatus. [ Read More ]
The intrinsic value of one
Shanghai Rongtai Health Technology Corp Ltd
stock under the Base Case scenario is
28.95
CNY.
Compared to the current market price of 22.1 CNY,
Shanghai Rongtai Health Technology Corp Ltd
is
Undervalued by 24%.
Shanghai Rongtai Health Technology Corp Ltd's market capitalization is 3B CNY.
Shanghai Rongtai Health Technology Corp Ltd stock price is 22.1 CNY.
Shanghai Rongtai Health Technology Corp Ltd stock price (22.1 CNY) is 24% less than its Intrinsic Value (28.95 CNY).
Shanghai Rongtai Health Technology Corp Ltd stock price (22.1 CNY) is 30% less than its DCF Value (31.42 CNY). Open DCF Valuation
Shanghai Rongtai Health Technology Corp Ltd stock price (22.1 CNY) is 17% less than its Relative Value (26.48 CNY). Open Relative Valuation
Shanghai Rongtai Health Technology Corp Ltd has upside potential of 15% compared to the average analyst price target.
Open Wall St Estimates
Shanghai Rongtai Health Technology Corp Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 10%.
Shanghai Rongtai Health Technology Corp Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 9%.
Shanghai Rongtai Health Technology Corp Ltd has positive Operating Income for the last twelve months.
Shanghai Rongtai Health Technology Corp Ltd has positive Net Income for the last twelve months.
Shanghai Rongtai Health Technology Corp Ltd has positive three-year average ROE (Return on Equity): 12%. The company is efficient at transforming stockholders' equity into net income.
Shanghai Rongtai Health Technology Corp Ltd's Revenue is forecast to grow at a rate of 5% per year over the next 3 years.
Shanghai Rongtai Health Technology Corp Ltd's ROE (Return on Equity) has decreased in the last 3 years from 14% to 10%.
Shanghai Rongtai Health Technology Corp Ltd has positive three-year average ROIC (Return on Invested Capital): 13%. The company is efficient at using invested capital to generate operating income.
Shanghai Rongtai Health Technology Corp Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 16% to 9%.
Shanghai Rongtai Health Technology Corp Ltd's Revenue has been falling by 6% per year for the last 3 years.
Shanghai Rongtai Health Technology Corp Ltd has positive Gross Profit for the last twelve months.
Shanghai Rongtai Health Technology Corp Ltd has positive Free Cash Flow for the last twelve months.
Shanghai Rongtai Health Technology Corp Ltd's Revenue has dropped by 25% over the past 12 months.
Shanghai Rongtai Health Technology Corp Ltd's Altman Z-Score is equal to 2.95.
Shanghai Rongtai Health Technology Corp Ltd has negative Net Debt. This means that the company has more cash and short-term investments (1B CNY) than debt (754m CNY).
Shanghai Rongtai Health Technology Corp Ltd's long-term assets (3B CNY) exceed its long-term liabilties (1B CNY).
Shanghai Rongtai Health Technology Corp Ltd's D/E (Debt to Equity) is very low and is equal to 0.38.
Shanghai Rongtai Health Technology Corp Ltd's short-term assets (2B CNY) exceed its short-term liabilties (534m CNY).
Valuation Backtest
Shanghai Rongtai Health Technology Corp Ltd
Run backtest to discover the historical profit from buying and selling
Shanghai Rongtai Health Technology Corp Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Shanghai Rongtai Health Technology Corp Ltd
Balance Sheet Decomposition
Shanghai Rongtai Health Technology Corp Ltd
| Current Assets | 2.1B |
| Cash & Short-Term Investments | 1.1B |
| Receivables | 220m |
| Other Current Assets | 789m |
| Non-Current Assets | 1.2B |
| Long-Term Investments | 248.5m |
| PP&E | 547.9m |
| Intangibles | 94.4m |
| Other Non-Current Assets | 330.7m |
| Current Liabilities | 534.4m |
| Accounts Payable | 267.4m |
| Accrued Liabilities | 38m |
| Short-Term Debt | 129m |
| Other Current Liabilities | 100m |
| Non-Current Liabilities | 753.1m |
| Long-Term Debt | 624.8m |
| Other Non-Current Liabilities | 128.4m |
Earnings Waterfall
Shanghai Rongtai Health Technology Corp Ltd
|
Revenue
|
1.7B
CNY
|
|
Cost of Revenue
|
-1.2B
CNY
|
|
Gross Profit
|
524.3m
CNY
|
|
Operating Expenses
|
-356.8m
CNY
|
|
Operating Income
|
167.5m
CNY
|
|
Other Expenses
|
22.8m
CNY
|
|
Net Income
|
190.3m
CNY
|
Free Cash Flow Analysis
Shanghai Rongtai Health Technology Corp Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Shanghai Rongtai Health Technology Corp Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai Rongtai Health Technology Corp Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai Rongtai Health Technology Corp Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai Rongtai Health Technology Corp Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai Rongtai Health Technology Corp Ltd
According to Wall Street analysts, the average 1-year price target for
Shanghai Rongtai Health Technology Corp Ltd
is 25.34 CNY
with a low forecast of 23.92 CNY and a high forecast of 27.3 CNY.
Shareholder Return
Price
Shanghai Rongtai Health Technology Corp Ltd
| Average Annual Return | -9.78% |
| Standard Deviation of Annual Returns | 19.78% |
| Max Drawdown | -62% |
| Market Capitalization | 3B CNY |
| Shares Outstanding | 135 625 521 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Shanghai Rongtai Health Technology Corp Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai Rongtai Health Technology Corp., Ltd. engages in the design, research, development, production, and sale of massage apparatus. The company is headquartered in Shanghai, Shanghai and currently employs 1,294 full-time employees. The company went IPO on 2017-01-11. The firm's products mainly include massage chairs and small massage appliances. In the domestic market, it mainly operates its own brand and provides original design manufacturer (ODM) production. In overseas markets, it provides ODM production for brands around the world, and promotes its own brand through e-commerce channels. The firm also provides shared massage services through the massage experience platform Momoda.
Contact
IPO
Employees
Officers
The intrinsic value of one
Shanghai Rongtai Health Technology Corp Ltd
stock under the Base Case scenario is
28.95
CNY.
Compared to the current market price of 22.1 CNY,
Shanghai Rongtai Health Technology Corp Ltd
is
Undervalued by 24%.
You don't have any saved screeners yet
